Ciprofloxacin (Cipro, BAYQ3939) ( DrugBank: Ciprofloxacin )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
299	Cystic fibrosis	2

299. Cystic fibrosis

---

Clinical trials : 1,696 /  Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00910351 (ClinicalTrials.gov)	July 2009	28/5/2009	Cipro Inhaler for Cystic Fibrosis Children Ages 6-12	A Study to Evaluate the Safety and Pharmacokinetics of Ciprofloxacin in Adults and Children Aged 6 - 12 Years With Cystic Fibrosis Following Inhalation of Ciprofloxacin Dry Powder	Pseudomonas Infection	Drug: Ciprofloxacin (Cipro, BAYQ3939)	Bayer	NULL	Completed	6 Years	12 Years	Both	19	Phase 1	United States
2	NCT00930982 (ClinicalTrials.gov)	June 2009	30/6/2009	Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis	Randomized, Placebo-controlled, Double-blind, Multi-center Study to Evaluate the Safety and Efficacy of Ciprofloxacin Inhale Compared to Placebo in Patients With Non-cystic Fibrosis Bronchiectasis	Bronchiectasis	Drug: Ciprofloxacin (Cipro, BAYQ3939);Drug: Placebo	Bayer	Novartis	Completed	18 Years	N/A	All	124	Phase 2	United States;Australia;Germany;Spain;Sweden;United Kingdom